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A New Mouse Model of Endometriosis
Endometriosis represents a huge socioeconomic burden, but
development of nonsurgical treatment has been hampered
by the lack of appropriate animal models. Greaves et al (Am
J Pathol 2014, 184:1930e1939) developed and validated a
mouse model of endometriosis using syngeneic menstrual
endometrial tissue introduced into the peritoneum of
immunnocompetent mice. The model closely mirrored the
human condition as an estrogen-dependent inﬂammatory
disorder and revealed that the immune complement of the
menstrual endometrium contributes to the pathology of
peritoneal lesions. This model offers the opportunity to
explore fully the pathobiology of this complex disorder and
the development of new therapeutic approaches.
Inﬂammasome Activation Mediates Mucositis
Cancer chemotherapy and radiotherapy frequently result in
mucositis, characterized by intense tissue damage. Arifa et al
(Am J Pathol 2014, 184:2023e2034) assessed mechanisms
and the role of inﬂammasome activation in mucositis induced
by the chemotherapeutic drug irinotecan in wild-type mice
and mice deﬁcient for various inﬂammasome components.
Irinotecan treatment resulted in increased IL-1b and IL-18
production in the ileum as well as NADPH oxidase 2
(NOX-2)dependent oxidative stress. In addition, the
absence of inﬂammasome system components ASC and
caspase-1 or IL-1b/IL-18 signaling reduced the inﬂammatory
response in irinotecan-induced mucositis. These results sug-
gest new therapeutic targets that could be useful for the treat-
ment of mucositis associated with chemotherapeutic agents.
Latent Tuberculosis Infection and Reactivation
Model
Lack of adequate models and molecular tools has impeded
the understanding of latent tuberculosis infection (LTBI).
Dutta et al (Am J Pathol 2014, 184:2045e2055) developed
and characterized a novel paucibacillary mouse model in
which mice develop necrotic lung granulomas following
infection with Mycobacterium tuberculosis. The progression
from latent to active infection was characterized both inCopyright ª 2014 American Society for Investigative Pathology.
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http://dx.doi.org/10.1016/j.ajpath.2014.04.016live animals and post-mortem using various molecular,
immunological, and imaging tools. The model faithfully
represented the hierarchy of sterilizing activities of standard
LTBI regimens. This model may be useful for identifying
novel treatment regimens, latent versus reactivation bio-
markers, and attenuated vaccine candidates.
EGFR and TP53 Cooperatively Transform
Schwann Cells
Malignant peripheral nerve sheath tumors (MPNSTs) are
aggressive, malignant tumors of Schwann cell origin, repre-
senting approximately 10% of diagnosed soft tissue sarcomas.
Rahrmann et al (Am J Pathol 2014, 184:2082e2098) per-
formed a comprehensive analysis of cooperativity between
EGFR overexpression and reduced TP53/Trp53 expression in
humanandmouseSchwanncell transformation.Co-alterationof
EGFR and TP53/Trp53 expression in vitro or in vivo, respec-
tively, contributed to Schwann cell tumorigenesis through
increased proliferation, anchorage-independent growth, PI3K/
Akt pathway activation, and chromosomal alterations enriching
for alterations in genes in the ERK5 signaling pathway. Thus,
EGFR and TP53 do cooperate to facilitate chromosomal aber-
rations leading to MPNST formation.
Targeting Cholesterol Suppresses Breast Cancer
Obesity and metabolic syndrome are linked to an increased
prevalence of breast cancer among postmenopausal women.
Using novel diet and feeding strategies, Pelton et al (Am J
Pathol 2014, 184:2099e2110) examined the speciﬁc effects
of hypercholesterolemia on tumor growth in an orthotopic
xenograft mouse model of breast cancer. A hypercholester-
olemic diet promoted tumor growth, whereas a low-fat, no-
cholesterol diet or treatment with the cholesterol-lowering
drug ezetimibe reduced circulating cholesterol and slowed
tumor growth. Histological and biochemical analyses
demonstrated that hypercholesterolemia increased cell pro-
liferation and tumor cell apoptosis and signiﬁcantly increased
tumor angiogenesis. Chemopreventive intervention to inhibit
breast cancer progression by lowering cholesterol pharma-
cologically, possibly in combination with diet, may therefore
be clinically effective.
